SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | – | 47,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $19,884,000 | 6.80% |
| Trellus Management Company, LLC | 662,612 | $1,279,000 | 1.06% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $7,084,000 | 0.89% |
| CVI Holdings, LLC | 1,550,960 | $2,993,000 | 0.56% |
| Nantahala Capital Management | 7,871,356 | $15,192,000 | 0.47% |
| AWM Investment Company, Inc. | 1,550,000 | $2,991,000 | 0.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 322,798 | $623,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,926,594 | $3,718,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,758,200 | $11,113,000 | 0.16% |
| Greylin Investment Management, Inc | 113,195 | $218,000 | 0.05% |